PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Biotage AB's PE Ratio without NRI is 50.22. Biotage AB's 5-Year EBITDA growth rate is 14.00%. Therefore, Biotage AB's PEG Ratio for today is 3.59.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Biotage AB's PEG Ratio or its related term are showing as below:
STU:PQX1'
s PEG Ratio Range Over the Past 10 Years
Min: 0.91 Med: 2.18 Max: 4.85
Current: 3.79
During the past 13 years, Biotage AB's highest PEG Ratio was 4.85. The lowest was 0.91. And the median was 2.18.
STU:PQX1's PEG Ratio is ranked worse than 72.06% of 247
companies
in the Medical Devices & Instruments industry
Industry Median: 1.84
vs STU:PQX1: 3.79
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Biotage AB PEG Ratio Historical Data
The historical data trend for Biotage AB's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Biotage AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotage AB's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Biotage AB's PEG Ratio falls into.
Biotage AB PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Biotage AB (STU:PQX1) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Biotage AB PEG Ratio Related Terms
Thank you for viewing the detailed overview of Biotage AB's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:PQX1 has been successfully added to your 